INCREASING TIM-3+T CELLS IN PERIPHERAL BLOOD OF PEDIATRIC PATIENTS WITH RELAPSE B-ALL AFTER HAPLOIDENTICAL ALLO-HSCT

被引：0

作者：

Tsvetkova, Liubov ^{[1
]}

Epifanovskaya, Olga ^{[1
]}

Babenko, Elena ^{[1
]}

Paina, Olesya ^{[1
]}

Kozhokar', Polina ^{[1
]}

Rakhmanova, Zhemal ^{[1
]}

Yudinceva, Olesya ^{[1
]}

Osipova, Anna ^{[1
]}

Ryabenko, Sabina ^{[1
]}

Dobrovolskaya, Elena ^{[1
]}

Moiseev, Ivan ^{[1
]}

Kulagin, Alexandr ^{[1
]}

Zubarovskaya, Ludmila ^{[1
]}

机构：

[1] Pavlov Univ, RM Gorbacheva Res Inst, St Petersburg, Russia

来源：

BONE MARROW TRANSPLANTATION | 2024年 / 59卷

基金：

俄罗斯科学基金会;

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

P680

引用

页码：613 / 614

页数：2

共 50 条

[41] The research of regulation of Tim-3+CD4+ and Tim-3+CD8+T cells on aGVHD after related HLA-haploidentical peripheral blood hematopoietic stem cell transplantation
Pang, N.
Yuan, H.
Duan, X.
Xu, J.
Qu, J.
Chen, G.
Jiang, M.
EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1487 - 1487
[42] SALVAGE THERAPIES AND OUTCOMES OF PATIENTS WITH RELAPSE OF B-ALL AFTER CD19 CAR T-CELL THERAPY
Friedes, Barbara
DiNofia, Amanda
Li, Yimei
Iannone, Emma
Rheingold, Susan
Leahy, Allison Barz
Wray, Lisa
Callahan, Colleen
Baniewicz, Diane
Liu, Hongyan
Getz, Kelly
Aplenc, Richard
Maude, Shannon
Grupp, Stephan
Myers, Regina
PEDIATRIC BLOOD & CANCER, 2023, 70 : S54 - S54
[43] Ruxolitinib treatment for acute gastrointestinal graft-versus-host disease caused by donor-derived CD19-Chimeric antigen receptor T-Cell infusion in a patient with B-ALL relapsed after Allo-HSCT
Yang, Yingying
Hu, Yongxian
Huang, He
REGENERATIVE THERAPY, 2019, 11 : 139 - 142
[44] Reduced Risk of Relapse In Pediatric ALL After Haploidentical Transplantation of T-Cell Depleted Grafts From KIR Haplotype B Donors
Oevermann, Lena
Michaelis, Sebastian
Mezger, Markus
Pfeiffer, Matthias
Lang, Peter
Feuchtinger, Tobias
Handgretinger, Rupert
BLOOD, 2011, 118 (21) : 1767 - 1767
[45] DIFFERENT RECOVERY PATTERNS OF CMV-SPECIFIC AND WT1SPECIFIC T CELLS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA UNDERGOING ALLO-HSCT: IMPACT OF CMV INFECTION AND LEUKEMIA RELAPSE
Luo, Xiao-Hua
Poiret, Thomas
Liu, Zhenjiang
Meng, Qingda
Nagchowdhury, Anurupa
Ljungman, Per
BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 279 - 280
[46] Analysis benefits of a second Allo-HSCT after CAR-T cell therapy in patients with relapsed/refractory B-cell acute lymphoblastic leukemia who relapsed after transplant
Cao, Xing-yu
Zhang, Jian-ping
Zhao, Yan-li
Xiong, Min
Zhou, Jia-rui
Lu, Yue
Sun, Rui-juan
Wei, Zhi-jie
Liu, De-yan
Zhang, Xian
Yang, Jun-fang
Lu, Peihua
FRONTIERS IN IMMUNOLOGY, 2023, 14
[47] COMPARISONS OF PROGNOSIS OF ALLO-HSCT AFTER CAR-T CELL THERAPY OR CHEMOTHERAPY IN PAEDIATRIC PATIENTS OF REFRACTORY/RELAPSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA : A MULTICENTER STUDY CCCG-ALL-2015
Li, Bohan
Chen, Jing
Luo, Chengjuan
Hu, Shaoyan
BONE MARROW TRANSPLANTATION, 2024, 59 : 603 - 604
[48] Level of Granzyme B-positive T-regulatory cells is a strong predictor biomarker of acute Graft-versus-host disease after day+30 after allo-HSCT
Drokov, Mikhail Y.
Davydova, Julia O.
Kuzmina, Larisa A.
Galtseva, Irina V.
Kapranov, Nikolay M.
Vasilyeva, Vera A.
Dubnyak, Darya S.
Koroleva, Olga M.
Mikhalcova, Ekaterina D.
Popova, Natalia N.
Parovichnikova, Elena N.
Savchenko, Valery G.
LEUKEMIA RESEARCH, 2017, 54 : 25 - 29
[49] Allogeneic CD34-Selected HSCT Following CAR T-Cells Is Associated with Low TRM and Favorable OS in Pediatric/Young Adult Patients with Relapsed/Refractory B-ALL
Fabrizio, Vanessa
Boulad, Farid
Cancio, Maria I.
Higman, Meghan A.
Margossian, Steven P.
Mauguen, Audrey
Prockop, Susan
Scaradavou, Andromachi
Shah, Niketa C.
Spitzer, Barbara
Yeager, Nick
Kernan, Nancy A.
O'Reilly, Richard
Boelens, Jaap Jan
Curran, Kevin J.
BLOOD, 2019, 134
[50] 多色流式细胞术检测微小残留病变在CD19-CAR-T桥接allo-HSCT治疗B-ALL患者监测的意义和价值
陈曼
赵玮
傅旻婧
王爱先
张改玲
邱丽媛
王榕
赵艳丽
张弦
王卉
中华检验医学杂志, 2022, 45 (08) : 813 - 819

← 1 2 3 4 5 →